Home Cart Sign in  
Chemical Structure| 54187-96-1 Chemical Structure| 54187-96-1
Chemical Structure| 54187-96-1

*Storage: Inert atmosphere,2-8°C.

*Shipping: Normal

1-(Chloromethyl)-1H-benzotriazole

CAS No.: 54187-96-1

4.5 *For Research Use Only !

Cat. No.: A853711 Purity: 98%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
10g łÇ§ď¶ÊÊ Inquiry 1-2 weeks Login
25g łË臨ÊÊ Inquiry 1-2 weeks Login

Please Login or Create an Account to: See VIP prices and availability

  • 10g

    łÇ§ď¶ÊÊ

  • 25g

    łË臨ÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 54187-96-1 ]

CAS No. :54187-96-1
Formula : C7H6ClN3
M.W : 167.60
SMILES Code : ClCN1N=NC2=CC=CC=C21
MDL No. :MFCD00216649
Boiling Point : No data available
InChI Key :VSEROABGEVRIRY-UHFFFAOYSA-N
Pubchem ID :3328222

Safety of [ 54187-96-1 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H290-H314
Precautionary Statements:P234-P260-P264-P280-P301+P330+P331+P310-P303+P361+P353+P310+P363-P304+P340+P310-P305+P351+P338+P310-P390-P405-P406-P501
Class:8
UN#:3261
Packing Group:

Calculated chemistry of [ 54187-96-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 9
Fraction Csp3 0.14
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 43.59
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

30.71 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.61
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.9
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.48
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.65
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.45
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.62

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.62
Solubility 0.406 mg/ml ; 0.00242 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.17
Solubility 1.14 mg/ml ; 0.0068 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.73
Solubility 0.314 mg/ml ; 0.00187 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.97 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.14

Application In Synthesis [ 54187-96-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 54187-96-1 ]

[ 54187-96-1 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 39998-25-9 ]
  • [ 54187-96-1 ]
  • [[2-[1-(benzotriazol-1-ylmethyl)pyridin-1-ium-3-yl]acetyl]amino]ammonium bistrifluoroacetate [ No CAS ]
  • 2
  • [ 39998-25-9 ]
  • [ 54187-96-1 ]
  • [ 76-05-1 ]
  • methyl 2-[1-(benzotriazol-1-ylmethyl)pyridin-1-ium-3-yl]acetate trifluoroacetate [ No CAS ]
YieldReaction ConditionsOperation in experiment
65% Methyl 3-pyridylacetate (81.6 mg, 0.540 mmol) was mixed with l-(chloromethyl)- 1 //-bcnzotriazolc (104.8 mg, 0.625 mmol) and dissolved in dry DMF (1 mL). The solution was stirred at 50 C for 3.5 d and was stopped by quenching with MeOH. The solvents were removed in vacuo and the crude mixture was subjected to preparative HPLC yielding 139.9 mg, 65%, of the desired product as a yellowish oil. (0592) HPLC method C-18 column: (0593) 0 min: 100% H20 0.1% TFA, 0% CHsCN 0.1% TFA; (0594) 0-60 min: 50% H2O 0.1% TFA, 50% CHsCN 0.1% TFA; (0595) 60-64 min: 2% H2O 0.1% TFA; 98% CHsCN 0.1% TFA; (0596) 64-80 min: 2% H2O 0.1% TFA; 98% CHsCN 0.1% TFA; (0597) 80-83 min: 60% H2O 0.1% TFA; 40% CHsCN 0.1% TFA; (0598) 83-89 min: 60% H2O 0.1% TFA; 40% CHsCN 0.1% TFA; (0599) 89-90 min: 60% H2O 0.1% TFA; 40% CHsCN 0.1% TFA. (0600) NMR (400 MHz, METHANOL-) d ppm 3.70 (s, 3 H) 4.04 (s, 2 H) 7.52 (dd, =7.68, 7.68 Hz, 1 H) 7.59 (s, 2 H) 7.70 (dd, =7.73, 7.73 Hz, 1 H) 8.04 - 8.08 (m, 2 H) 8.16 (dd, J=1.91, 6.34 Hz, 1 H) 8.64 (d, =8.03 Hz, 1 H) 9.22 (d, =6. l5 Hz, 1 H) 9.33 (s, 1 H). (0601) 13C NMR (101 MHz, METHANOL-^) d ppm 36.17 (1 C) 51.69 (1 C) 68.18 (1 C) 109.40 (1 C) 119.65 (1 C) 125.31 (1 C) 128.08 (1 C) 129.39 (1 C) 132.60 (1 C) 137.13 (1 C) 142.57 (1 C) 144.66 (1 C) 145.87 (1 C) 149.18 (1 C) 169.75 (1 C). (0602) HPLC -MS (m/z) [M]+ calcd 283.11950 found 283.41.
 

Related Products

Technical Information

Categories